scispace - formally typeset
A

Anitha Ravikrishnan

Researcher at University of Delaware

Publications -  14
Citations -  657

Anitha Ravikrishnan is an academic researcher from University of Delaware. The author has contributed to research in topics: Gene delivery & PEGylation. The author has an hindex of 11, co-authored 14 publications receiving 548 citations. Previous affiliations of Anitha Ravikrishnan include State University of New York System.

Papers
More filters
Journal ArticleDOI

Overcoming Nonviral Gene Delivery Barriers: Perspective and Future

TL;DR: This work presents the existing delivery barriers and summarize current vector-specific strategies to overcome said barriers, and focuses on the gene delivery barriers associated with the two most common classes of nonviral vectors, cationic-based lipids and polymers.
Journal ArticleDOI

Poly(ethylene glycol)-block-cationic polylactide nanocomplexes of differing charge density for gene delivery

TL;DR: Results help to elucidate the influence of charge, size, and PEGylation of nanocomplexes upon the delivery of nucleic acids in physiologically relevant conditions.
Journal ArticleDOI

Mannosylated poly(beta-amino esters) for targeted antigen presenting cell immune modulation

TL;DR: The gene delivery effectiveness provided by mannosylated PBAE vectors offers specificity and potency in directing APC activation and subsequent immune responses and is presented as a new class of easily synthesized APC-targeting cationic polymers.
Journal ArticleDOI

Biomaterials-based strategies for salivary gland tissue regeneration

TL;DR: Although the in vitro engineering of a complex implantable salivary gland is technically challenging, opportunities exist for multidisciplinary teams to assemble implantable and secretory tissue modules by combining stem/progenitor cells found in the adult glands with biomimetic and cell-instructive materials.
Journal ArticleDOI

Hybrid biosynthetic gene therapy vector development and dual engineering capacity

TL;DR: The hybrid device demonstrated a strong, efficient, and safe in vivo humoral immune response compared with traditional forms of antigen delivery and combined and synergized normally disparate vector properties and tools, resulting in increased in vitro gene delivery beyond individual vector components or commercially available transfection agents.